52
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Postural Tachycardia Syndrome: A Heterogeneous and Multifactorial Disorder

      review-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Postural tachycardia syndrome (POTS) is defined by a heart rate increment of 30 beats/min or more within 10 minutes of standing or head-up tilt in the absence of orthostatic hypotension; the standing heart rate is often 120 beats/min or higher. POTS manifests with symptoms of cerebral hypoperfusion and excessive sympathoexcitation. The pathophysiology of POTS is heterogeneous and includes impaired sympathetically mediated vasoconstriction, excessive sympathetic drive, volume dysregulation, and deconditioning. POTS is frequently included in the differential diagnosis of chronic unexplained symptoms, such as inappropriate sinus tachycardia, chronic fatigue, chronic dizziness, or unexplained spells in otherwise healthy young individuals. Many patients with POTS also report symptoms not attributable to orthostatic intolerance, including those of functional gastrointestinal or bladder disorders, chronic headache, fibromyalgia, and sleep disturbances. In many of these cases, cognitive and behavioral factors, somatic hypervigilance associated with anxiety, depression, and behavioral amplification contribute to symptom chronicity. The aims of evaluation in patients with POTS are to exclude cardiac causes of inappropriate tachycardia; elucidate, if possible, the most likely pathophysiologic basis of postural intolerance; assess for the presence of treatable autonomic neuropathies; exclude endocrine causes of a hyperadrenergic state; evaluate for cardiovascular deconditioning; and determine the contribution of emotional and behavioral factors to the patient's symptoms. Management of POTS includes avoidance of precipitating factors, volume expansion, physical countermaneuvers, exercise training, pharmacotherapy (fludrocortisone, midodrine, β-blockers, and/or pyridostigmine), and behavioral-cognitive therapy. A literature search of PubMed for articles published from January 1, 1990, to June 15, 2012, was performed using the following terms (or combination of terms): POTS; postural tachycardia syndrome, orthostatic; orthostatic; syncope; sympathetic; baroreceptors; vestibulosympathetic; hypovolemia; visceral pain; chronic fatigue; deconditioning; headache; Chiari malformation; Ehlers-Danlos; emotion; amygdala; insula; anterior cingulate; periaqueductal gray; fludrocortisone; midodrine; propranolol; β-adrenergic; and pyridostigmine. Studies were limited to those published in English. Other articles were identified from bibliographies of the retrieved articles.

          Related collections

          Author and article information

          Contributors
          Journal
          Mayo Clin Proc
          Mayo Clin. Proc
          Mayo Clinic Proceedings
          Mayo Foundation
          0025-6196
          1942-5546
          December 2012
          : 87
          : 12
          : 1214-1225
          Affiliations
          Department of Neurology, Mayo Clinic, Rochester, MN
          Author notes
          [* ] Correspondence: Address to Eduardo E. Benarroch, MD, Department of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN 55905 benarroch.eduardo@ 123456mayo.edu
          Article
          PMC3547546 PMC3547546 3547546 JMCP243
          10.1016/j.mayocp.2012.08.013
          3547546
          23122672
          d05b0183-7ce8-495f-8781-1c9e3260c793
          © 2012 Published by Elsevier Inc. on behalf of Mayo Foundation for Medical Education and Research.
          History
          Categories
          Review

          EDS, Ehlers-Danlos syndrome,POTS, postural tachycardia syndrome,NET, norepinephrine transporter,NE, norepinephrine,HUT, head-up tilt

          Comments

          Comment on this article

          Related Documents Log